论文部分内容阅读
目的:探讨剖宫产术前静滴催产素对母婴的影响。方法:对2004年1～12月,择期剖宫产术的初产妇40例,术前静滴催产素(研究组),同时选择40例择期剖宫产作为对照组,两组孕次、剖宫产术指征、妊娠时间、年龄、胎儿体重及胎盘情况差异无显著性(P>0.05)。结果:研究组术中及术后2h、2～24h出血量(108±31.2ml、91±53.2ml、89±60.2ml)明显低于对照组(282±56.3ml、184±61.8ml、122±63.0ml)(P<0.01),剖宫产术前术后24h血红蛋白(Hb)及红细胞压积(HCT)的变化两组无显著性差异(P>0.05),两组新生儿情况有显著性差异(P<0.01)。结论:剖宫产术前静滴催产素对母婴预后优于术中及术后催产素的应用。
Objective: To investigate the effect of intravenous oxytocin on maternal and infant before cesarean section. Methods: From January to December 2004, 40 cases of primipara of elective cesarean section, preoperative intravenous infusion of oxytocin (study group), 40 cases of elective cesarean section as control group, Indications of uterine surgery, gestational age, age, fetal weight and placental differences were not statistically significant (P> 0.05). Results: The blood loss (108 ± 31.2ml, 91 ± 53.2ml, 89 ± 60.2ml) in the study group at 2h and 2 ~ 24h after operation was significantly lower than that in the control group (282 ± 56.3ml, 184 ± 61.8ml, 122 ± 63.0ml) (P <0.01). There was no significant difference in hemoglobin (Hb) and hematocrit (HCT) between the two groups before cesarean section (P> 0.05) Difference (P <0.01). CONCLUSION: Intravenous oxytocin before cesarean section is better than intraoperative and postoperative oxytocin in prognosis of maternal and infant.